Percentiles of Lymphocyte Subsets in Preterm Infants According to Gestational Age Compared to Children and

S Huenecke1, E Fryns2, B Wittekindt2

  • 1Clinic for Pediatric and Adolescent Medicine, University Hospital, Frankfurt, Germany . sabine.huenecke@kgu.de.

Insights

Preterm infants have immature immune systems, increasing infection risk. This study establishes lymphocyte subset references for preterm infants, aiding in understanding their immune development and potential disorders.

Area of Science:

  • Immunology
  • Neonatology
  • Pediatrics

Background:

  • Preterm newborns exhibit heightened susceptibility to infections due to immature immune systems.
  • Understanding immune system development in preterm infants is crucial for managing their health.
  • Early immune cell profiles can indicate potential immunological challenges.

Purpose of the Study:

  • To establish reference ranges for lymphocyte subsets in early preterm infants.
  • To compare immune cell maturation in preterm infants during hospitalization with healthy term-born individuals.
  • To provide data for assessing the immunological capability of preterm infants.

Main Methods:

  • Prospective observational study involving 40 preterm infants (gestational age 26-30 weeks) and 10 term neonates.
  • Peripheral blood samples analyzed using 10-colour flow cytometry for immune cell subsets.
  • Development of a percentile model based on preterm infant age for lymphocyte, B cell, T cell, NK cell, T8, and T4 cell counts.

Main Results:

  • Established median cell counts for T-, B-, and NK cells post-birth.
  • Identified significant differences in absolute B cell counts and regulatory T cell frequencies, particularly in the earliest preterm infants (GA 26).
  • Preterm infants approached the 5th to 50th percentile of lymphocyte counts by hospital discharge compared to healthy children.

Conclusions:

  • This study provides the first reference percentiles for lymphocyte subsets in preterm infants.
  • The data supports the interpretation of immunological status in preterm infants, aiding in the identification of immune disorders.
  • These findings are valuable for clinical management and further research into preterm infant immunity.

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.1K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
419
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
351
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Percentile01:18

Percentile

A percentile indicates the relative standing of a data value when data are sorted into numerical order from smallest to largest. It represents the percentages of data values that are less than or equal to the pth percentile. For example, 15% of data values are less than or equal to the 15th percentile.
9.6K